SCHEDULE: FMR LLC & Abigail Johnson Boost Harmony Biosciences Stake to 6.7%

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a 6.7% beneficial ownership stake in Harmony Biosciences Holdings Inc. as of September 30, 2025.

Summary

• FMR LLC and Abigail P. Johnson reported beneficial ownership of 3,846,972.08 shares of Harmony Biosciences Holdings Inc. common stock.
• This represents 6.7% of the company's outstanding common stock.
• FMR LLC holds sole voting power over 3,845,850.00 shares and sole dispositive power over 3,846,972.08 shares.
• Abigail P. Johnson, as a Director, Chairman, and CEO of FMR LLC, is deemed to beneficially own the same aggregate amount of shares due to the Johnson family's controlling interest in FMR LLC.
• The filing is an Amendment No. 6 to a Schedule 13G, indicating previous disclosures of ownership.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Harmony Biosciences Holdings Inc.

Sentiment

Score: 6

Explanation: The filing indicates a substantial and continued institutional investment by FMR LLC and Abigail P. Johnson in Harmony Biosciences Holdings Inc., which can be viewed as a vote of confidence. However, it is a routine beneficial ownership disclosure and does not contain new operational or financial performance information from the issuer.

Positives

• Increased institutional ownership by a major investment firm like FMR LLC can signal confidence in Harmony Biosciences Holdings Inc.'s long-term prospects.
• A 6.7% stake represents a significant commitment from a prominent institutional investor.

Future Outlook

NA

Industry Context

Schedule 13G filings are standard disclosures by institutional investors who acquire more than 5% of a company's voting shares, indicating a passive investment intent. FMR LLC, as a major asset manager, frequently files such reports across various industries, and this filing reflects its continued or adjusted stake in Harmony Biosciences Holdings Inc., a company likely operating in the biotechnology or pharmaceutical sector given its name.

Stakeholder Impact

• Shareholders: The continued significant stake by a major institutional investor like FMR LLC may be viewed positively, potentially enhancing investor confidence and market stability.

Key Dates

Keywords

Harmony Biosciences Holdings Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Equity Stake, 413197104